Creative Biolabs-Immuno-oncology

Anti-EPHB2 (clone 2EH9Q) SynExpress C-Cy3-TF-Sm Modified CD8+ T cells (CAT#: ITS-1224-CR654)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target EPHB2 (clone 2EH9Q). We employs the pUC (CMV-Cy3-TFIIA-SmaI) vector components and the SynExpress system of the Exons Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
EPHB2
Clone
2EH9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
TFIIA
Insertion Sites
SmaI
Gene Modification
Prime Editing
Modification Domain
Exons
Carrier Type
pUC
Transformation Accuracy
0.96
Cell Culture
Plate Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.